US2018104401A1PendingUtilityA1
Method for peritoneal removal of electrolytes and inflammatory mediators
Est. expiryOct 19, 2036(~10.2 yrs left)· nominal 20-yr term from priority
A61M 1/287B01D 15/34A61M 2202/0468A61M 2205/04A61M 2205/75A61M 1/285A61M 1/28
45
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method of peritoneal removal of electrolytes and inflammatory mediators. The method begins with infusing a treatment solution into the peritoneal cavity of a patient by way of a catheter. The treatment solution is drained from the peritoneal cavity by way of the catheter. During the draining, the treatment solution is filtered for removing electrolytes and inflammatory mediators.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of peritoneal removal of electrolytes and inflammatory mediators, the method comprising:
infusing a treatment solution into the peritoneal cavity of a patient by way of a catheter; draining, by way of the catheter, the treatment solution from the peritoneal cavity; and filtering electrolytes and inflammatory mediators from the treatment solution while the treatment solution is draining.
2 . The method of claim 1 , wherein filtering electrolytes and inflammatory mediators further comprises:
positioning a filter in fluid communication with the catheter, the filter comprising:
a proximal end;
a distal end;
a lumen extending between the proximal and distal ends; and
a filler within the lumen of the filter, the filler configured to remove electrolytes, inflammatory mediators, or both by size exclusion.
3 . The method of claim 2 , wherein the filler is selected from the group consisting of:
a polymer, a resin, or diffusion tubes configured to remove inflammatory mediators.
4 . The method of claim 2 , the filler comprising a binding agent configured to selectively bind electrolytes, inflammatory mediators, or both.
5 . The method of claim 4 , wherein the binding agent is selected from the group consisting of:
a polymer, a resin, or diffusion tubes configured to remove inflammatory mediators.
6 . The method of claim 1 , wherein infusing the treatment solution further comprises:
a treatment solution container fluidically coupled to a distal end of the catheter, the treatment solution container configured to support the treatment solution.
7 . The method of claim 6 , wherein infusing the treatment solution further comprises:
elevating the treatment solution container above an infusion site of the patient.
8 . The method of claim 6 , wherein draining the treatment solution further comprises:
lowering the treatment solution container below an infusion site of the patient.
9 . The method of claim 6 , further comprising:
elevating the treatment solution container above an infusion site of the patient for infusing the treatment solution; and lowering the treatment solution container below the infusion site for draining the treatment solution.
10 . The method of claim 1 , wherein the treatment solution comprises:
saline; and a binding agent configured to selectively bind electrolytes, inflammatory mediators, or both.
11 . A method of peritoneal removal of electrolytes and inflammatory mediators, the method comprising:
elevating a treatment solution container above an infusion site of the patient; while elevating, infusing a treatment solution from the treatment solution into the peritoneal cavity of the patient by way of a catheter; lowering the treatment solution container below the infusion site for draining the treatment solution; while lowering, draining, by way of the catheter, the treatment solution from the peritoneal cavity; and filtering electrolytes and inflammatory mediators from the treatment solution during the infusing, during the draining, or both.
12 . The method of claim 11 , wherein filtering electrolytes and inflammatory mediators further comprises:
positioning a filter in fluid communication with the catheter, the filter comprising:
a proximal end;
a distal end;
a lumen extending between the proximal and distal ends; and
a filler within the lumen of the filter, the filler configured to remove electrolytes, inflammatory mediators, or both.
13 . The method of claim 12 , wherein the filler is selected from the group consisting of:
a polymer, a resin, or diffusion tubes configured to remove inflammatory mediators.
14 . The method of claim 11 , wherein filtering electrolytes and inflammatory mediators further comprises:
positioning a filter in fluid communication with the catheter, the filter comprising:
a proximal end;
a distal end;
a lumen extending between the proximal and distal ends; and
a filler within the lumen of the filter, the filler comprising a binding agent configured to selectively bind electrolytes, inflammatory mediators, or both.
15 . The method of claim 14 , wherein the binding agent is selected from the group consisting of:
a polymer, a resin, or diffusion tubes configured to remove inflammatory mediators.
16 . The method of claim 11 , wherein the treatment solution comprises:
saline; and a binding agent configured to selectively bind electrolytes, inflammatory mediators, or both.
17 . The method of claim 11 , further comprising:
re-instilling the treatment solution by, again, elevating the treatment solution container above the infusion site.
18 . The method of claim 17 , further comprising:
again draining the treatment solution by again lowering the treatment solution container to below the infusion site.
19 . A method of peritoneal removal of electrolytes and inflammatory mediators, the method comprising:
implanting a filter cartridge in the peritoneal cavity of a patient; infusing a treatment solution into the peritoneal cavity of a patient; and drawing the treatment solution from the peritoneal cavity through the filter cartridge; wherein the filter cartridge comprises a binding agent enclosed within a porous surgical packing material.
20 . The method of claim 19 , wherein drawing the treatment solution further comprises:
pulling the treatment solution from the peritoneal cavity by way of a would drain.
21 . The method of claim 20 , wherein the wound drain is fluidically coupled to a pump.
22 . The method of claim 19 , further comprising:
re-instilling the treatment solution into the peritoneal cavity.
23 . The method of claim 19 , wherein the binding agent is configured to selectively bind electrolytes, inflammatory mediators, or both.
24 . The method of claim 23 , wherein the binding agent is selected from the group consisting of:
a polymer, a resin, or diffusion tubes configured to remove inflammatory mediators.Join the waitlist — get patent alerts
Track US2018104401A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.